Home/Filings/4/0000950170-25-063521
4//SEC Filing

ARMEN GARO H 4

Accession 0000950170-25-063521

CIK 0001098972other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:05 PM ET

Size

7.2 KB

Accession

0000950170-25-063521

Insider Transaction Report

Form 4
Period: 2025-05-02
ARMEN GARO H
DirectorSee Remarks
Transactions
  • Award

    Common Stock

    2025-05-02$3.11/sh+5,260$16,359181,060 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    31,298
  • Common Stock

    (indirect: See Footnote)
    28,950
Footnotes (4)
  • [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 2, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
  • [F2]$3.11 is the closing price of our Common Stock on May 2, 2025, the last trading day for the payroll date for the pay period ending May 2, 2025.
  • [F3]Shares are held in Dr. Armen's IRA accounts.
  • [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

AGENUS INC

CIK 0001098972

Entity typeother

Related Parties

1
  • filerCIK 0000935679

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:05 PM ET
Size
7.2 KB